T1	Participants 29 49	rheumatoid arthritis
T2	Participants 227 261	patients with rheumatoid arthritis
T3	Participants 380 545	Two hundred and one functional class I and II patients with definite or classic rheumatoid arthritis, previously untreated with disease modifying antirheumatic drugs
T4	Participants 2116 2188	sole antirheumatic therapy in patients with active rheumatoid arthritis.
